Kennedy Capital Management’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-20,692
Closed -$1.86M 579
2025
Q4
$1.86M Sell
20,692
-72
-0.3% -$6.83K 0.04% 427
2025
Q3
$2.05M Sell
20,764
-4,831
-19% -$479K 0.05% 447
2025
Q2
$2.33M Sell
25,595
-3,396
-12% -$328K 0.06% 424
2025
Q1
$3.28M Sell
28,991
-2,435
-8% -$260K 0.08% 356
2024
Q4
$3.32M Buy
31,426
+6,505
+26% +$698K 0.07% 406
2024
Q3
$2.69M Buy
24,921
+1,135
+5% +$124K 0.06% 458
2024
Q2
$2.58M Buy
23,786
+9,864
+71% +$1.16M 0.06% 476
2024
Q1
$1.84M Buy
+13,922
New +$1.74M 0.04% 531
2016
Q4
Sell
-50,834
Closed -$6.42M 769
2016
Q3
$6.42M Sell
50,834
-2,238
-4% -$277K 0.12% 294
2016
Q2
$6.2M Sell
53,072
-7,498
-12% -$849K 0.13% 289
2016
Q1
$6.27M Sell
60,570
-4,309
-7% -$417K 0.13% 288
2015
Q4
$6.46M Sell
64,879
-1,003
-2% -$98.1K 0.13% 281
2015
Q3
$6.01M Sell
65,882
-4,516
-6% -$453K 0.12% 309
2015
Q2
$7.47M Sell
70,398
-2,064
-3% -$228K 0.13% 268
2015
Q1
$8.27M Buy
72,462
+2,605
+4% +$297K 0.14% 255
2014
Q4
$7.69M Buy
69,857
+2,014
+3% +$212K 0.14% 267
2014
Q3
$6.62M Buy
67,843
+1,110
+2% +$109K 0.13% 295
2014
Q2
$6.73M Sell
66,733
-36,356
-35% -$3.55M 0.13% 313
2014
Q1
$9.47M Buy
103,089
+2,556
+3% +$236K 0.18% 206
2013
Q4
$9.1M Sell
100,533
-451
-0.4% -$39K 0.17% 231
2013
Q3
$8.05M Buy
100,984
+970
+1% +$76.4K 0.16% 238
2013
Q2
$7.28M Buy
+100,014
New +$7.48M 0.15% 264

Other funds holding ZBH

Kennedy Capital Management's ZBH Position: Q1 2026 in Review

Kennedy Capital Management sold out of Zimmer Biomet (ZBH) in Q1 2026, closing a stake of 20,692 shares — an estimated $1.86M sold.

Kennedy Capital Management first reported a position in ZBH in Q2 2013 and held it in 22 quarters. The position peaked at $9.47M in Q1 2014. 916 funds tracked by Wall St. Rank hold ZBH as of Q1 2026.

  • Kennedy Capital Management reported no remaining Zimmer Biomet position as of Q1 2026 after selling out during the quarter.
  • Kennedy Capital Management sold 20,692 Zimmer Biomet shares in Q1 2026, an estimated $1.86M.
  • Kennedy Capital Management first reported a position in Zimmer Biomet in Q2 2013 and held it in 22 quarters.
  • Kennedy Capital Management's Zimmer Biomet position peaked at $9.47M in Q1 2014.
  • 916 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2026.

Based on Kennedy Capital Management's 13F filing for Q1 2026, filed 13 May 2026.